Metaplanet
3350
Mitsui O.S.K. Lines
9104
Oriental Land
4661
4
Toyota Motor
7203
5
Tokyo Metro
9023
JP Stock MarketDetailed Quotes
4593 Healios KK
- 323
- +3+0.94%
20min DelayMarket Closed Apr 30 15:30 JST
32.77BMarket Cap-6.75P/E (Static)
341High321Low8.48MVolume325Open320Pre Close2.78BTurnover40852wk High21.45%Turnover Ratio101.46MShares12552wk Low-47.86EPS TTM12.78BFloat Cap2669Historical HighLossP/E (Static)39.56MShs Float114Historical Low-47.86EPS LYR6.25%Amplitude--Dividend TTM15.89P/B100Lot Size--Div YieldTTM
About Healios KK Company
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.
Company Profile
Symbol4593
Company NameHealios KK
Founded2011-02-24
MarketTSE Growth
Employees65
Fiscal Year Ends12-31
AddressWorld Trade Center Bldg. 15th Floor 2-4-1 Hamamatsucho
Zip Code100-0006
Phone03-4590-8009
Websitewww.healios.co.jp
Company Executives
- Name
- Position
- Salary
- Tadanao Kagimoto
- Director
- --
- Richard P. Kincaid
- Director
- --
- Michihisa Nishiyama
- Director
- --
- Yuko Yogo
- Independent Director
- --
- Seigo Kashii
- Independent Director
- --
- Glenn Gormley
- Independent Director
- --